Drug intelligence / Profile preview

nicotine inhaler

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Inhalation, Oral Inhalation
01

Overview

The nicotine inhaler is a prescription smoking cessation aid consisting of a mouthpiece and a plastic cartridge that delivers 4 mg of nicotine from a porous plug containing 10 mg nicotine. Unlike cigarettes or asthma inhalers, the nicotine is absorbed primarily in the mouth and throat rather than the lungs. Users take frequent, short puffs over about 20 minutes per cartridge. The inhaler helps reduce nicotine withdrawal symptoms and cigarette cravings by providing controlled nicotine delivery without the harmful chemicals found in cigarette smoke. It's recommended for use as part of a comprehensive behavioral smoking cessation program.

Brand names
Nicotrol InhalerNicorette Inhaler
Other names
nicotine inhalation systemnicotine oral inhalation
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)CHRNA7 (α7 nicotinic receptor)

Beyond the preview

Go deeper on nicotine inhaler.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotine inhaler.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call